Who founded Tavros Therapeutics?

Tavros Therapeutics was founded by Kris Wood, Eoin McDonnell in 2019.

Who are Tavros Therapeutics's investors?

Tavros Therapeutics's investors include Alexandria, KdT Ventures.

Tavros Therapeutics has disclosed $8.5M raised across 2 rounds.

Tavros Therapeutics is headquartered in Durham, US.

Durham, US · Founded 2019 · Delaware corporation · 3 known investors

Tavros Therapeutics was founded in 2019 by Kris Wood and Eoin McDonnell.

Kris WoodCo-founder

Eoin McDonnellCo-founder

Piedmont Capital Investmentslead

SEC filings, press & company announcements

$8.5M disclosed across 2 rounds · 2020–2022

$7.5MSeed IISep 2022 · 2 sources
KdT Ventures (lead), Piedmont Capital Investments (lead), Alexandria Venture Investments
Source ↗

▶$1000KraisedMar 2020 · 1 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Who founded Tavros Therapeutics?: Tavros Therapeutics was founded by Kris Wood, Eoin McDonnell in 2019.
Who are Tavros Therapeutics's investors?: Tavros Therapeutics's investors include Alexandria, KdT Ventures.
How much funding has Tavros Therapeutics raised?: Tavros Therapeutics has disclosed $8.5M raised across 2 rounds.
Where is Tavros Therapeutics headquartered?: Tavros Therapeutics is headquartered in Durham, US.